Biotech Lesaffre strengthens its Research, Development & Innovation (RD&I) with the acquisition of Altar, a company owned by Ginkgo Bioworks October 7, 2024
Biotech Satellite Symposium Addresses The Role of Advanced Multiplex Molecular Testing in Diagnostic Stewardship October 6, 2024
Biotech Charles Dadswell to step down as General Counsel, Illumina initiates search for successor October 4, 2024
Biotech Enzyme-Linked Immunosorbent Assay (ELISA) Market to Grow by USD 843.9 Million (2024-2028) as AI Drives Demand for Frequent Diagnostic Testing October 4, 2024
Biotech IDEAYA Biosciences Announces Late-Breaker Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36th Edition of the EORTC-NCI-AACR Symposium October 4, 2024
Biotech IDEAYA Biosciences Announces Late-Breaker Oral Presentation of IDE397 Phase 1 Expansion Results in MTAP-Deletion Lung and Urothelial Cancer at the 36th Edition of the EORTC-NCI-AACR Symposium October 4, 2024
Biotech Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment October 3, 2024
Biotech Expert Systems Celebrates Milestone in Clinical Development of Ratutrelvir, Potential Best-in-Class COVID Candidate October 3, 2024